Continuation of Research and Development Activities
First written in FY2017-Q1. 23 of 29 entries say "Restated". Latest entry: FY2025-H1.
97 other companies' latest entry also says "Restated".
- FY2025-H1RestatedAnnual report
「Total research and development expenses for the current interim consolidated accounting period were ¥377 million. There were no significant changes in the status of research and development activities during the current interim consolidated accounting period.」
The disclosure states that there were no significant changes in research and development activities and reports total interim-period research and development expenses of ¥377 million. - FY2024-Q3RestatedAnnual report
「Total research and development expenses for the cumulative third quarter of the current consolidated fiscal period were ¥536 million. There were no significant changes in the status of research and development activities during the cumulative third quarter of the current consolidated fiscal period.」
The disclosure states that there were no significant changes in research and development activities and reports cumulative research and development expenses of ¥536 million for the third quarter. - FY2024-Q2RestatedAnnual report
「Total research and development expenses for the cumulative second quarter of the current consolidated fiscal period were ¥370 million. There were no significant changes in the status of research and development activities during the cumulative second quarter of the current consolidated fiscal period.」
The Company recorded total research and development expenses of ¥370 million and stated that there were no significant changes in the status of research and development activities. - FY2024-Q1RestatedAnnual report
「Total research and development expenses for the cumulative first quarter of the current consolidated fiscal period were ¥178 million. There were no significant changes in the status of research and development activities during the cumulative first quarter of the current consolidated fiscal period.」
The disclosure states that there were no significant changes in research and development activities and reports total research and development expenses of ¥178 million. - FY2023AdvancedAnnual report
「The Group's research and development organization is centered on the research institute and Production Engineering Department under the Production Engineering Division. The newly expanded Functional Materials Development Office is strengthening development activities aimed at securing new adoptions. In addition, the Company established a Cup Business Promotion Office and is focusing on securing new adoptions for cup-related products.」
While continuing its research and development activities, the Company strengthened development for new adoptions by expanding the Functional Materials Development Office and establishing the Cup Business Promotion Office. Research and development expenses across all segments were ¥702 million. - FY2023-Q3RestatedAnnual report
「Total research and development expenses for the cumulative third quarter of the current consolidated fiscal period were ¥503 million. There were no significant changes in the status of research and development activities during the cumulative third quarter of the current consolidated fiscal period.」
The disclosure states that there were no significant changes in research and development activities and reports total research and development expenses of ¥503 million. - FY2023-Q2RestatedAnnual report
「Total research and development expenses for the cumulative second quarter of the current consolidated fiscal period were ¥336 million. There were no significant changes in the status of research and development activities during the cumulative second quarter of the current consolidated fiscal period.」
The Company recorded total research and development expenses of ¥336 million and stated that there were no significant changes in the status of research and development activities. - FY2023-Q1RestatedAnnual report
「Total research and development expenses for the cumulative first quarter of the current consolidated fiscal period were ¥179 million. There were no significant changes in the status of research and development activities during the cumulative first quarter of the current consolidated fiscal period.」
The disclosure states that there were no significant changes in research and development activities and reports total research and development expenses of ¥179 million. - FY2022AdvancedAnnual report
「A notable development was the Company's participation in the "Project to Build a Satellite from Paper" conducted by Teraspace Co., Ltd., a venture developing ultra-small satellites. The Company's new CNF-based product ReCell was selected as a material for demonstration testing in the project.」
CNF research has continued, ReCell was selected as a material for demonstration testing in a paper satellite project, and preparations are also under way to commercialize nanocarbon sheets. - FY2022-Q3RestatedAnnual report
「Total research and development expenses for the cumulative third quarter of the current consolidated fiscal period were ¥433 million. There were no significant changes in the status of research and development activities during the cumulative third quarter of the current consolidated fiscal period.」
The disclosure states that there were no significant changes in research and development activities and reports total research and development expenses of ¥433 million. - FY2022-Q1RestatedAnnual report
「Total research and development expenses for the cumulative first quarter of the current consolidated fiscal period were ¥123 million. There were no significant changes in the status of research and development activities during the cumulative first quarter of the current consolidated fiscal period.」
The disclosure states that there were no significant changes in research and development activities and reports total research and development expenses of ¥123 million. - FY2021AdvancedAnnual report
「In a national project joined in fiscal 2020 with the University of Tokyo, Kyoto University, Osaka University and others, the Company is contributing to innovative technology development toward a low-CO2 society through a group responsible for the precise structural analysis of CNF and the formation of thermally insulating porous materials.」
Research and development activities have progressed beyond continuation, with the Company participating in a national project with universities and others and working on the precise structural analysis of CNF and the formation of thermally insulating porous materials. Research and development expenses across all segments were ¥666 million. - FY2021-Q3RestatedAnnual report
「Total research and development expenses for the cumulative third quarter of the current consolidated fiscal period were ¥519 million. There were no significant changes in the status of research and development activities during the cumulative third quarter of the current consolidated fiscal period.」
The disclosure states that there were no significant changes in research and development activities and reports total research and development expenses of ¥519 million. - FY2021-Q2RestatedAnnual report
「Total research and development expenses for the cumulative second quarter of the current consolidated fiscal period were ¥352 million. There were no significant changes in the status of research and development activities during the cumulative second quarter of the current consolidated fiscal period.」
The disclosure states that there were no significant changes in research and development activities and reports total research and development expenses of ¥352 million. - FY2021-Q1RestatedAnnual report
「Total research and development expenses for the cumulative first quarter of the current consolidated fiscal period were ¥192 million. There were no significant changes in the status of research and development activities during the cumulative first quarter of the current consolidated fiscal period.」
The disclosure states that there were no significant changes in research and development activities and reports total research and development expenses of ¥192 million. - FY2020-Q3RestatedAnnual report
「Total research and development expenses for the cumulative third quarter of the current consolidated fiscal period were ¥511 million. There were no significant changes in the status of research and development activities during the cumulative third quarter of the current consolidated fiscal period.」
The disclosure states that there were no significant changes in research and development activities and reports total research and development expenses of ¥511 million. - FY2020-Q2RestatedAnnual report
「Total research and development expenses for the cumulative second quarter of the current consolidated fiscal period were ¥339 million. There were no significant changes in the status of research and development activities during the cumulative second quarter of the current consolidated fiscal period.」
The disclosure states that there were no significant changes in research and development activities and reports total research and development expenses of ¥339 million. - FY2020-Q1RestatedAnnual report
「Total research and development expenses for the cumulative first quarter of the current consolidated fiscal period were ¥168 million. There were no significant changes in the status of research and development activities during the cumulative first quarter of the current consolidated fiscal period.」
The disclosure states that there were no significant changes in research and development activities and reports total research and development expenses of ¥168 million. - FY2019-Q3RestatedAnnual report
「Total research and development expenses for the cumulative third quarter of the current consolidated fiscal period were ¥554 million. There were no significant changes in the status of research and development activities during the cumulative third quarter of the current consolidated fiscal period.」
The disclosure states that there were no significant changes in research and development activities and reports total research and development expenses of ¥554 million. - FY2019-Q2RestatedAnnual report
「Total research and development expenses for the cumulative second quarter of the current consolidated fiscal period were ¥375 million. There were no significant changes in the status of research and development activities during the cumulative second quarter of the current consolidated fiscal period.」
The disclosure states that there were no significant changes in research and development activities and reports total research and development expenses of ¥375 million. - FY2019-Q1RestatedAnnual report
「Total research and development expenses for the cumulative first quarter of the current consolidated fiscal period were ¥197 million. There were no significant changes in the status of research and development activities during the cumulative first quarter of the current consolidated fiscal period.」
The disclosure states that there were no significant changes in research and development activities and reports total research and development expenses of ¥197 million. - FY2018AdvancedAnnual report
「In April 2017, the Company established a New Functional Materials Development Office and began full-scale efforts to develop and commercialize new functional materials, including CNF, as well as applications for the Company's specialty paper products and nanocarbon materials, in addition to three-dimensional porous materials such as air-purification filters and ultra-low-density porous materials (aerogels). From fiscal 2018, the Company also began joint research with the Niigata Prefectural Institute of Technology on the development of surface-coating agents using CNF.」
Following the establishment of the New Functional Materials Development Office, the Company expanded the applications of CNF and began joint research with the Niigata Prefectural Institute of Technology. - FY2018-Q3RestatedAnnual report
「Total research and development expenses for the cumulative third quarter of the current consolidated fiscal period were ¥544 million. There were no significant changes in the status of research and development activities during the cumulative third quarter of the current consolidated fiscal period.」
The disclosure states that there were no significant changes in research and development activities and reports total research and development expenses of ¥544 million. - FY2018-Q2RestatedAnnual report
「Total research and development expenses for the cumulative second quarter of the current consolidated fiscal period were ¥371 million. There were no significant changes in the status of research and development activities during the cumulative second quarter of the current consolidated fiscal period.」
The disclosure states that there were no significant changes in research and development activities and reports total research and development expenses of ¥371 million. - FY2018-Q1RestatedAnnual report
「Total research and development expenses for the cumulative first quarter of the current consolidated fiscal period were ¥199 million. There were no significant changes in the status of research and development activities during the cumulative first quarter of the current consolidated fiscal period.」
The disclosure states that there were no significant changes in research and development activities and reports total research and development expenses of ¥199 million. - FY2017AdvancedAnnual report
「The Company has successfully developed a high-performance air-purification filter medium in which CNF is webbed through the gaps between glass fibers, as well as an ultra-low-density, high-surface-area porous material known as an aerogel. CNF, or cellulose nanofiber, is a lightweight, strong, plant-based material made by refining plant fibers such as wood pulp to the nanoscale.」
The disclosure has progressed from the previous statement that there were no significant changes in research and development activities to reporting the successful development of CNF-based air-purification filter media and aerogels, as well as the establishment of a New Functional Materials Development Office. - FY2017-Q3RestatedAnnual report
「Total R&D expenses for the third quarter of the current consolidated cumulative period were ¥622 million. There were no material changes in R&D activities during the third quarter of the current consolidated cumulative period.」
The company states that there were no material changes in R&D activities and reports total R&D expenses of ¥622 million. - FY2017-Q2RestatedAnnual report
「Total R&D expenses for the second quarter of the current consolidated cumulative period were ¥382 million. There were no material changes in R&D activities during the second quarter of the current consolidated cumulative period.」
The company states that there were no material changes in R&D activities and reports total R&D expenses of ¥382 million. - FY2017-Q1First statedAnnual report
「Total research and development expenses for the first quarter were ¥201 million. There were no material changes in research and development activities during the first quarter.」
Research and development expenses totaled ¥201 million, with no material changes in R&D activities.